175 related articles for article (PubMed ID: 23525846)
1. Use of panitumumab-IRDye800 to image cutaneous head and neck cancer in mice.
Heath CH; Deep NL; Beck LN; Day KE; Sweeny L; Zinn KR; Huang CC; Rosenthal EL
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):982-90. PubMed ID: 23525846
[TBL] [Abstract][Full Text] [Related]
2. Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model.
Heath CH; Deep NL; Sweeny L; Zinn KR; Rosenthal EL
Ann Surg Oncol; 2012 Nov; 19(12):3879-87. PubMed ID: 22669455
[TBL] [Abstract][Full Text] [Related]
3. Identification of the optimal therapeutic antibody for fluorescent imaging of cutaneous squamous cell carcinoma.
Day KE; Beck LN; Heath CH; Huang CC; Zinn KR; Rosenthal EL
Cancer Biol Ther; 2013 Mar; 14(3):271-7. PubMed ID: 23298904
[TBL] [Abstract][Full Text] [Related]
4. Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma.
Day KE; Sweeny L; Kulbersh B; Zinn KR; Rosenthal EL
Mol Imaging Biol; 2013 Dec; 15(6):722-9. PubMed ID: 23715932
[TBL] [Abstract][Full Text] [Related]
5. Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma.
Day KE; Beck LN; Deep NL; Kovar J; Zinn KR; Rosenthal EL
Laryngoscope; 2013 Nov; 123(11):2681-9. PubMed ID: 23616260
[TBL] [Abstract][Full Text] [Related]
6. Use of monoclonal antibody-IRDye800CW bioconjugates in the resection of breast cancer.
Korb ML; Hartman YE; Kovar J; Zinn KR; Bland KI; Rosenthal EL
J Surg Res; 2014 May; 188(1):119-28. PubMed ID: 24360117
[TBL] [Abstract][Full Text] [Related]
7. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.
Sampath L; Kwon S; Ke S; Wang W; Schiff R; Mawad ME; Sevick-Muraca EM
J Nucl Med; 2007 Sep; 48(9):1501-10. PubMed ID: 17785729
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic antibody improves melanoma detection by fluorescently labeled therapeutic antibodies.
Sweeny L; Prince A; Patel N; Moore LS; Rosenthal EL; Hughley BB; Warram JM
Laryngoscope; 2016 Dec; 126(12):E387-E395. PubMed ID: 27576611
[TBL] [Abstract][Full Text] [Related]
9. Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer.
Nishio N; van den Berg NS; van Keulen S; Martin BA; Fakurnejad S; Zhou Q; Lu G; Chirita SU; Kaplan MJ; Divi V; Colevas AD; Rosenthal EL
Mol Imaging Biol; 2020 Feb; 22(1):156-164. PubMed ID: 31054001
[TBL] [Abstract][Full Text] [Related]
10. The Use of Panitumumab-IRDye800CW in a Novel Murine Model for Conjunctival Squamous Cell Carcinoma.
Youn GM; Case AG; Jarin T; Li B; Swarup A; Naranjo A; Bou-Khalil C; Yao J; Zhou Q; Hom ME; Rosenthal EL; Wu AY
Transl Vis Sci Technol; 2022 Jul; 11(7):23. PubMed ID: 35895055
[TBL] [Abstract][Full Text] [Related]
11. Effect of Formalin Fixation for Near-Infrared Fluorescence Imaging with an Antibody-Dye Conjugate in Head and Neck Cancer Patients.
Kapoor S; Lu G; van den Berg NS; Krishnan G; Pei J; Zhou Q; Martin BA; Baik FM; Rosenthal EL; Nishio N
Mol Imaging Biol; 2021 Apr; 23(2):270-276. PubMed ID: 33078373
[TBL] [Abstract][Full Text] [Related]
12. Factors for Differential Outcome Across Cancers in Clinical Molecule-Targeted Fluorescence Imaging.
Zhou Q; van den Berg NS; Kang W; Pei J; Nishio N; van Keulen S; Engelen MA; Lee YJ; Hom M; Vega Leonel JCM; Hart Z; Vogel H; Cayrol R; Martin BA; Roesner M; Shields G; Lui N; Gephart MH; Raymundo RC; Yi G; Granucci M; Grant GA; Li G; Rosenthal EL
J Nucl Med; 2022 Nov; 63(11):1693-1700. PubMed ID: 35332092
[TBL] [Abstract][Full Text] [Related]
13. Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts.
Rosenthal EL; Kulbersh BD; King T; Chaudhuri TR; Zinn KR
Mol Cancer Ther; 2007 Apr; 6(4):1230-8. PubMed ID: 17431103
[TBL] [Abstract][Full Text] [Related]
14. EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial.
Zhou Q; van den Berg NS; Rosenthal EL; Iv M; Zhang M; Vega Leonel JCM; Walters S; Nishio N; Granucci M; Raymundo R; Yi G; Vogel H; Cayrol R; Lee YJ; Lu G; Hom M; Kang W; Hayden Gephart M; Recht L; Nagpal S; Thomas R; Patel C; Grant GA; Li G
Theranostics; 2021; 11(15):7130-7143. PubMed ID: 34158840
[No Abstract] [Full Text] [Related]
15. PET of EGFR antibody distribution in head and neck squamous cell carcinoma models.
Niu G; Li Z; Xie J; Le QT; Chen X
J Nucl Med; 2009 Jul; 50(7):1116-23. PubMed ID: 19525473
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts.
Kulbersh BD; Duncan RD; Magnuson JS; Skipper JB; Zinn K; Rosenthal EL
Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):511-5. PubMed ID: 17520766
[TBL] [Abstract][Full Text] [Related]
17. Panitumumab-IRDye800CW for Fluorescence-Guided Surgical Resection of Colorectal Cancer.
Marston JC; Kennedy GD; Lapi SE; Hartman YE; Richardson MT; Modi HM; Warram JM
J Surg Res; 2019 Jul; 239():44-51. PubMed ID: 30798171
[TBL] [Abstract][Full Text] [Related]
18. Molecular imaging of a fluorescent antibody against epidermal growth factor receptor detects high-grade glioma.
Zhou Q; Vega Leonel JCM; Santoso MR; Wilson C; van den Berg NS; Chan CT; Aryal M; Vogel H; Cayrol R; Mandella MJ; Schonig F; Lu G; Gambhir SS; Moseley ME; Rosenthal EL; Grant GA
Sci Rep; 2021 Mar; 11(1):5710. PubMed ID: 33707521
[TBL] [Abstract][Full Text] [Related]
19. Fluorescently Labeled Cetuximab-IRDye800 for Guided Surgical Excision of Ameloblastoma: A Proof of Principle Study.
Morlandt AB; Moore LS; Johnson AO; Smith CM; Stevens TM; Warram JM; MacDougall M; Rosenthal EL; Amm HM
J Oral Maxillofac Surg; 2020 Oct; 78(10):1736-1747. PubMed ID: 32554066
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]